Galantamine

Pronunciation: guh-LAN-tuh-meen.

Generic name
galantamine
Drug class
Cholinesterase inhibitor (reversible, competitive acetylcholinesterase inhibitor and allosteric nicotinic receptor modulator)
Form
Immediate-release tablet and oral solution (twice daily); extended/prolonged-release capsule (once daily)
Route
Oral
Legal status
Prescription-only

Availability and supply rules vary by country

Trade names by country: United States · United Kingdom · Canada · Australia · New Zealand

Australia: Reminyl (5) · Full directory

What galantamine is and how it works

Galantamine is a prescription medicine that increases the amount of acetylcholine (a brain chemical involved in memory and thinking) by blocking the enzyme that breaks it down, and by boosting nicotinic receptor activity. It is used to treat symptoms of mild to moderate, or moderately severe, Alzheimer's disease dementia. (1) (2)

Galantamine does not stop or reverse Alzheimer's disease, but it may help with memory, thinking, and daily function for some people for a period of time. It has genuine cardiac and skin-reaction risks that need to be discussed with a clinician before and during treatment, and dosing is started low and increased slowly to reduce side effects.

Mechanism of action: how galantamine works

Galantamine is a reversible, competitive inhibitor of acetylcholinesterase and also allosterically modulates nicotinic acetylcholine receptors, increasing central cholinergic transmission thought to be relevant to the cognitive symptoms of Alzheimer's disease. (1) (3) (4)

What galantamine is used for

Mild to moderate (or moderately severe) Alzheimer's disease dementia

Used to treat symptoms of Alzheimer's disease dementia, such as difficulties with memory, thinking, and daily activities. It has not been shown to be effective in other types of dementia or other causes of memory impairment. (1) (2) (4)

Before taking galantamine

Do not take / not appropriate for

  • Do not take galantamine if you have a known hypersensitivity to galantamine or any of the tablet/capsule/solution ingredients. (all countries) (1) (2)
  • Do not take galantamine if you have severe liver impairment, or both significant kidney and liver problems together. (all countries) (2) (1)
  • Do not take galantamine if your kidney function is very severely reduced (creatinine clearance below 9 mL/min). (all countries) (1) (2)

Tell your clinician about

  • Any history of slow heart rate, heart block, unexplained fainting, or any heart rhythm problem, including a prolonged QT interval, or if you take other medicines that can affect heart rhythm.
  • Any history of stomach ulcers, gastrointestinal bleeding, or if you take NSAID pain relievers regularly.
  • Any history of asthma or severe COPD, seizures, or difficulty passing urine (possible bladder outflow obstruction).
  • All other medicines you take, especially other cholinesterase inhibitors, medicines that affect heart rhythm, or muscle relaxants used during anaesthesia (such as succinylcholine).
  • Whether you are pregnant, plan to become pregnant, or are breastfeeding.
  • Any unexplained weight loss, as this needs to be monitored during treatment.
(1) (2) (4)

How to take galantamine

  • There are two different dosing schedules depending on which formulation you have been prescribed -- always follow the instructions for your specific product.
  • Immediate-release tablets or oral solution are taken twice daily, ideally with morning and evening meals, with adequate fluid intake.
  • Extended/prolonged-release capsules are taken once daily in the morning, preferably with food, and swallowed whole (not chewed or crushed).
  • Do not change your dose or stop taking galantamine without your clinician's guidance -- doses are increased slowly, over weeks, to reduce side effects.
(1) (2) (4)

Procedures and treatment changes

Tell the treating team before surgery, procedures, or any medicine change. Do not alter treatment without the responsible clinician. (1) (2) (3) (4) (5) (6)

Missed dose

If you miss a dose, contact your prescriber or care team for guidance rather than doubling the next dose. If several days of doses are missed, do not simply resume at the previous dose without checking with your clinician, since restarting at too high a dose can increase side effects.

Overdose

Seek urgent medical attention if you think too much galantamine has been taken, or if you develop severe nausea/vomiting, a very slow heart rate, fainting, severe muscle weakness, seizures, or collapse -- overdose has been associated with dangerous heart rhythm changes (torsade de pointes). (3) (1)

Side effects

Side effects and their urgency vary; report severe, persistent, or concerning symptoms.

Nausea and vomiting, especially during dose increases (often improving within about a week).

What to notice: Nausea and vomiting, especially during dose increases (often improving within about a week).

What to do: Discuss persistent or troublesome symptoms with the treating clinician or pharmacist. (1) (2)

Diarrhoea and decreased appetite.

What to notice: Diarrhoea and decreased appetite.

What to do: Discuss persistent or troublesome symptoms with the treating clinician or pharmacist. (1) (4)

Dizziness, headache, and tremor.

What to notice: Dizziness, headache, and tremor.

What to do: Discuss persistent or troublesome symptoms with the treating clinician or pharmacist. (1) (6)

Weight decrease.

What to notice: Weight decrease.

What to do: Discuss persistent or troublesome symptoms with the treating clinician or pharmacist. (1) (4)

Serious warnings

Signs of a slow or irregular heartbeat, or fainting — high caution

Symptoms: Very slow heartbeat, dizziness, fainting or near-fainting, palpitations, or an irregular heartbeat.

Action: Contact your clinician promptly, or seek emergency care if fainting or collapse occurs -- galantamine can slow heart conduction (bradycardia, AV block) and, per a 2020 European safety review, has been linked to QTc-interval prolongation and a dangerous heart rhythm problem (torsade de pointes), particularly in overdose or with other heart-rhythm-affecting medicines. (1) (2) (3)

Signs of a serious skin reaction — emergency

Symptoms: A new or spreading skin rash, blistering or peeling skin, or sores in the mouth, eyes, or genitals.

Action: Seek medical attention immediately at the first sign of a rash, and ask whether you should keep taking galantamine -- rare but serious skin reactions (Stevens-Johnson syndrome, acute generalised exanthematous pustulosis) have been reported, and your clinician will decide whether treatment should be paused. (1) (2) (4) (5)

Signs of gastrointestinal bleeding — high caution

Symptoms: Black or tarry stools, vomiting blood or material that looks like coffee grounds, or severe stomach pain.

Action: Seek urgent medical attention -- this is more likely if you have a history of stomach ulcers or take NSAID pain relievers regularly. (1) (2) (4)

Unintended, significant weight loss — monitor

Symptoms: Losing 7% or more of body weight, particularly in women, or ongoing loss of appetite.

Action: Tell your clinician -- weight should be monitored during treatment, and your clinician may need to reassess your dose or nutrition. (4) (2)

Interactions

  • Other cholinesterase inhibitors, cholinergic agonists, and muscle relaxants used in anaesthesia (such as succinylcholine) may have synergistic (additive) effects with galantamine. (1) (4)
  • Anticholinergic medicines may work less well when taken with galantamine. (1) (4)
  • Strong CYP2D6 or CYP3A4 inhibitors (such as paroxetine or ketoconazole) can increase galantamine levels in the body (paroxetine has been shown to increase exposure by up to 40-48%); a dose reduction may be needed. (2) (4)
  • Other medicines that slow the heart rate or affect the QT interval may increase the risk of cardiac side effects when combined with galantamine. (3) (2)

Pregnancy, breastfeeding, kidney/liver function, age

Pregnancy

Safety in human pregnancy has not been established; animal studies showed developmental toxicity at clinically relevant doses. Use only if the potential benefit is judged to justify the potential risk, and discuss with your clinician. (1) (2) (3) (4) (5) (6)

Breastfeeding

Data on use during breastfeeding are not available across the sources reviewed; discuss with your clinician before breastfeeding while taking galantamine. (1) (2) (3) (4) (5) (6)

Children

Not indicated for use in children -- galantamine is approved only for Alzheimer's disease dementia in adults. (1) (2) (3) (4) (5) (6)

Elderly

Slower dose titration is recommended in patients over 85 years of age, per the Canadian product monograph. (1) (2) (3) (4) (5) (6)

Hepatic_impairment

Moderate hepatic impairment: dose should generally not exceed 16 mg/day (or the equivalent extended-release regimen), with slower titration. Severe hepatic impairment (Child-Pugh score above 9): contraindicated. (1) (2) (3) (4) (5) (6)

Renal_impairment

No dose adjustment needed if creatinine clearance is 9 mL/min or above but caution and slower titration is advised; a maximum of 16 mg/day applies in moderate impairment. Creatinine clearance below 9 mL/min: contraindicated. (1) (2) (3) (4) (5) (6)

Source_ids

US-DAILYMED-GALANTAMINE-2026,UK-EMC-GALANTAMINE-2026,CA-HC-REMINYL-ER-PM-2026 (1) (2) (3) (4) (5) (6)

Monitoring

Before starting

  • Baseline heart rate/rhythm assessment, especially in patients with known cardiac conduction problems or unexplained syncope
  • Baseline weight
  • Review of other medicines for cholinergic, cardiac, or CYP2D6/3A4-interacting effects
  • Liver and kidney function, to guide dosing

During treatment

  • Ongoing monitoring for bradycardia, syncope, or other cardiac symptoms, especially during dose increases
  • Body weight monitoring, given the association with clinically significant weight loss
  • Prompt assessment of any new skin rash
  • Assessment for signs of GI bleeding, especially in patients with ulcer history or concurrent NSAID use
(1) (2) (4)

Storage

Store at room temperature in the original packaging, protected from moisture, out of reach of children.

Professional information

Clinician-facing context only, sourced from the current US FDA DailyMed label and the UK/Canada regulatory documents reviewed; verify against the current full label before prescribing.

United States / New Zealand

Indication: Mild to moderate Alzheimer's disease dementia (immediate-release tablets/oral solution)

Dose summary: 4 mg twice daily, titrated at intervals of at least 4 weeks to 8 mg twice daily, then to a maximum of 12 mg twice daily.

Renal context: Moderate hepatic/renal impairment: do not exceed 16 mg/day; severe hepatic impairment or CrCl <9 mL/min: contraindicated. (1) (6)

United Kingdom / European Union / Canada

Indication: Mild to moderately severe Alzheimer's disease dementia (extended/prolonged-release capsules)

Dose summary: 8 mg once daily for 4 weeks, then 16 mg once daily for at least 4 weeks, then up to a maximum of 24 mg once daily.

Renal context: Moderate hepatic impairment: 8 mg every other day then 8 mg daily, maximum 16 mg/day; severe hepatic impairment not recommended; renal impairment (CrCl 9-60 mL/min): cautious escalation, maximum 16 mg/day; severe renal impairment not recommended. (2) (4)

Mechanism of action

Overdose note

Cholinergic crisis features (severe nausea, vomiting, salivation, sweating, bradycardia, hypotension, seizures, and increasing muscle weakness) may occur; QTc prolongation and torsade de pointes have been reported in overdose. Manage with supportive care and cardiac monitoring; atropine may be considered by treating clinicians as an antidote for muscarinic effects. (1) (3) (4)

Frequently asked questions

Is galantamine available in the US, UK, Europe, Canada, Australia, and New Zealand?

Yes. It is authorised in all of these regions, generally now available as generic galantamine alongside or instead of the original brand Reminyl (renamed Razadyne in the United States). (1) (2) (3) (4) (5) (6)

Does galantamine affect the heart?

Yes -- galantamine can slow heart conduction, causing bradycardia or AV block, with a dose-related risk of fainting. A 2020 European safety review also added a warning about QTc-interval prolongation and a dangerous heart rhythm problem called torsade de pointes, particularly in overdose or when combined with other medicines that affect heart rhythm. (1) (3)

What is the difference between immediate-release and extended-release galantamine?

Immediate-release tablets and oral solution are taken twice daily. Extended/prolonged-release capsules (marketed as Razadyne ER, Reminyl ER, or Reminyl XL, and as generic prolonged-release capsules) are taken once daily. The two forms have different starting doses and titration steps, so it's important to follow the instructions for the specific product prescribed. (1) (2) (4)

What is the mechanism of action of galantamine?

Galantamine is a reversible, competitive inhibitor of acetylcholinesterase and also allosterically modulates nicotinic acetylcholine receptors, increasing central cholinergic transmission thought to be relevant to the cognitive symptoms of Alzheimer's disease. (1) (3) (4)

What is the generic name of Galantamine?

The generic name is galantamine. (1) (2)

What class of drug is galantamine?

Galantamine is classed as: Cholinesterase inhibitor (reversible, competitive acetylcholinesterase inhibitor and allosteric nicotinic receptor modulator). (1) (2)

References

  1. GALANTAMINE tablets, for oral use -- full prescribing informationU.S. Food and Drug Administration / DailyMed (NIH), full prescribing information · United States · accessed 2026-07-31 · source 1
  2. Galantamine 24 mg prolonged-release hard capsules -- Summary of Product Characteristicselectronic medicines compendium (emc), United Kingdom -- KRKA UK Ltd · United Kingdom · accessed 2026-07-31 · source 2
  3. Galantamine -- CMDh scientific conclusions and grounds for variation to the terms of the marketing authorisation(s) (PSUSA/00001512/202003)European Medicines Agency (EMA) -- PRAC/CMDh scientific conclusions and grounds for variation · European Union · accessed 2026-07-31 · source 3
  4. REMINYL ER (galantamine hydrobromide extended-release capsules) -- Product MonographHealth Canada product monograph, Janssen Inc. · Canada · accessed 2026-07-31 · source 4
  5. REMINYL galantamine 8 mg (as hydrobromide) modified-release capsule blister pack -- ARTG entry 97883Therapeutic Goods Administration (TGA), Australia · Australia · accessed 2026-07-31 · source 5
  6. REMINYL Capsules -- New Zealand Data SheetMedsafe (New Zealand regulator) · New Zealand · accessed 2026-07-31 · source 6

Brand names by country

Single-ingredient galantamine names are shown separately by country. Product availability, strengths, and supply rules can change; combination products are not included here.

Priority countries

United States

  • Razadyne / Razadyne ER (generic: galantamine) (1)FDA approved currently labeled · 4 mg, 8 mg, 12 mg (tablets, twice daily), 8 mg / 16 mg / 24 mg (ER capsules, once daily) · Multiple generic manufacturers (e.g. Upsher-Smith Laboratories, Golden State Medical Supply); originally Janssen

United Kingdom

  • Galantamine (generic, multiple manufacturers) (2)MHRA licensed emc smpc confirmed · 8 mg, 16 mg, 24 mg prolonged-release capsules · KRKA UK Ltd (and other generic manufacturers e.g. Aurobindo/Gaalin)
  • Reminyl / Reminyl XL (2)previously marketed originator brand · 4 mg/8 mg/12 mg tablets/oral solution (Reminyl), 8 mg/16 mg/24 mg (Reminyl XL) · Takeda UK Ltd (originator; some presentations now discontinued in favour of generics)

Canada

  • GALANTAMINE ER
  • PAT-GALANTAMINE ER
  • MYLAN-GALANTAMINE ER
  • TEVA-GALANTAMINE ER
  • PMS-GALANTAMINE ER
  • MAR-GALANTAMINE ER
  • AURO-GALANTAMINE ER

Australia

  • Reminyl (5)TGA ARTG registered active confirmed · 8 mg modified-release capsule (ARTG 97883) · Clinect Pty Ltd

New Zealand

  • Reminyl (6)Medsafe registered confirmed · 4 mg/8 mg/12 mg capsules, 8 mg/16 mg/24 mg modified-release capsules · Janssen-Cilag (New Zealand) Ltd
View brands in additional countries.

European Union

Galantamine (nationally authorised, multiple generic and originator brands) (3)

This page provides general reference information about galantamine and is not a substitute for advice from the prescriber managing your treatment. All dosing and treatment decisions should be made with your prescriber.

Related medicines

Related conditions